Debt-to-equity of Cidara Therapeutics, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cidara Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Cidara Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 19%, a 82% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Cidara Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 19% -88% -82% 30 Sep 2025
Q2 2025 20% -241% -92% 30 Jun 2025
Q1 2025 35% +991% 31 Mar 2025
Q4 2024 54% -8077% -99% 31 Dec 2024
Q3 2024 106% +9535% 30 Sep 2024
Q2 2024 261% -31168% -99% 30 Jun 2024
Q1 2024 -956% +315% +25% 31 Mar 2024
Q4 2023 8131% +8767% 31 Dec 2023
Q3 2023 -9429% -7327% -349% 30 Sep 2023
Q2 2023 31428% +33591% 30 Jun 2023
Q1 2023 -1271% -2157% -243% 31 Mar 2023
Q4 2022 -636% -1333% -191% 31 Dec 2022
Q3 2022 -2102% -2845% -383% 30 Sep 2022
Q2 2022 -2163% -2481% -781% 30 Jun 2022
Q1 2022 886% +685% +340% 31 Mar 2022
Q4 2021 697% +589% +545% 31 Dec 2021
Q3 2021 743% +664% +846% 30 Sep 2021
Q2 2021 318% +248% +358% 30 Jun 2021
Q1 2021 201% +135% +204% 31 Mar 2021
Q4 2020 108% +44% +68% 31 Dec 2020
Q3 2020 79% +28% +55% 30 Sep 2020
Q2 2020 69% +29% +71% 30 Jun 2020
Q1 2020 66% +32% +92% 31 Mar 2020
Q4 2019 64% +31% +93% 31 Dec 2019
Q3 2019 51% +18% +54% 30 Sep 2019
Q2 2019 41% +7.7% +23% 30 Jun 2019
Q1 2019 35% +0.69% +2% 31 Mar 2019
Q4 2018 33% +3.8% +13% 31 Dec 2018
Q3 2018 33% +6.7% +25% 30 Sep 2018
Q2 2018 33% +12% +55% 30 Jun 2018
Q1 2018 34% +19% +123% 31 Mar 2018
Q4 2017 29% +19% +176% 31 Dec 2017
Q3 2017 26% +20% +295% 30 Sep 2017
Q2 2017 21% +16% +327% 30 Jun 2017
Q1 2017 15% +11% +272% 31 Mar 2017
Q4 2016 11% +5.2% +96% 31 Dec 2016
Q3 2016 6.6% -0.48% -6.7% 30 Sep 2016
Q2 2016 5% 30 Jun 2016
Q1 2016 4.1% 31 Mar 2016
Q4 2015 5.4% 31 Dec 2015
Q3 2015 7.1% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.